Volume 26, Issue 4 pp. 793-796
CASE REPORT

Visceral extra-abdominal panniculitis after COVID19

Cristina Ausín-García

Corresponding Author

Cristina Ausín-García

Internal Medicine Service, General University Hospital Gregorio Marañón, Madrid, Spain

Correspondence

Cristina Ausín-García, Internal Medicine Service, General University Hospital Gregorio Marañón 28007, Madrid, Spain.

Email: [email protected]

Search for more papers by this author
Eva Cervilla-Muñoz

Eva Cervilla-Muñoz

Internal Medicine Service, General University Hospital Gregorio Marañón, Madrid, Spain

Search for more papers by this author
Pablo Demelo-Rodríguez

Pablo Demelo-Rodríguez

Internal Medicine Service, General University Hospital Gregorio Marañón, Madrid, Spain

Search for more papers by this author
María Victoria Villalba-García

María Victoria Villalba-García

Internal Medicine Service, General University Hospital Gregorio Marañón, Madrid, Spain

Search for more papers by this author
Luis A. Alvarez-Sala Walther

Luis A. Alvarez-Sala Walther

Internal Medicine Service, General University Hospital Gregorio Marañón, Madrid, Spain

Search for more papers by this author
First published: 24 December 2022

Abstract

“Retractile mesenteritis” was the first name given to a rare, benign, inflammatory disease that affects the adipose tissue of the intestinal mesentery and less frequently other locations. Now labeled as mesenteric panniculitis, the pathogenic mechanism remains unclear. Several stimuli could be involved, and it is sometimes associated with other conditions such as malignancy or autoimmune diseases. We present a case of mesenteric panniculitis with extensive abdominal and extra-abdominal involvement that developed a few months after SARS-COV2 infection, raising the hypothesis of this virus as a potential trigger for autoinflammatory and autoimmune diseases.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.